Chemical Compound
(+/-)-Methoxyverapamil; Benzeneacetonitrile, a-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4,5-trimethoxy-a-(1-methylethyl)-; Valeronitrile, 5-[(3,4-dimethoxyphenethyl)methylamino]-2-isopropyl-2-(3,4,5-trimethoxyphenyl)- (8CI); a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]met
CAS Registry Number
16662-47-8
Primary record
(+/-)-Methoxyverapamil; Benzeneacetonitrile, a-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4,5-trimethoxy-a-(1-methylethyl)-; Valeronitrile, 5-[(3,4-dimethoxyphenethyl)methylamino]-2-isopropyl-2-(3,4,5-trimethoxyphenyl)- (8CI); a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]met
- 库存
- 5,289 克
- 纯度
- 99.5 %
- CAS
- 16662-47-8
化合物标识与属性
- CAS
- 16662-47-8
- PubChem CID
- 1234
- SMILES
- CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C(=C2)OC)OC)OC
- Canonical SMILES
- COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC
名称与同义词
- Gallopamil
- methoxyverapamil
- Galopamilo
- Gallopamillum
- Procorum
- 16662-47-8
- Elgiprona
- Prebet
- Gallopamil HCl
- Galopamilo [INN-Spanish]
- Gallopamil (INN)
- Gallopamil [INN:BAN]
- (+-)-Gallopamil
- Gallopamillum [INN-Latin]
- (+/-)-Methoxyverapamil
- 39WPC8JHR8
- GALLO?
- GALLOPAMIL [MI]
- UNII-39WPC8JHR8
- C28H40N2O5
- Gallopamil [BAN:INN]
- GALLOPAMIL [INN]
- Hydrochloride, Gallopamil
- RefChem:634116
- Methoxyverapamil hydrochloride
- D00ERV
- D08FVE
- D0G4RQ
- 5-((3,4-Dimethoxyphenethyl)(methyl)amino)-2-isopropyl-2-(3,4,5-trimethoxyphenyl)pentanenitrile
- AC1L1B0T
- AC1Q4QM2
- GALLOPAMIL [WHO-DD]
- Lopac0_000778
- SCHEMBL49428
- BSPBio_001383
- DTXSID5045172
- KBioGR_000103
- KBioSS_000103
- CHEMBL51149
- D600
- D-600
- GALLOPAMIL HYDROCHLORIDE
- XQLWNAFCTODIRK-UHFFFAOYSA-N
- (+/-)-Methoxyverapamil hydrochloride
- orb1309646
- D 600
- DL-D-600
- DTXCID3025172
- SCHEMBL29563394
- BDBM82061
- CHEBI:34772
- CTK8C4103
- KBio2_000103
- KBio2_002671
- KBio2_005239
- KBio3_000205
- KBio3_000206
- MSK10644A
- C08DA02
- CID1234
- MFCD00867067
- Bio1_000389
- Bio1_000878
- Bio1_001367
- Bio2_000103
- Bio2_000583
- HMS1791F05
- HMS1989F05
- METHOXYVERAPAMILHYDROCHLORIDE
- LU-30-029
- 8484AA
- ANW-71056
- AR-1L1796
- HSCI1_000351
- MFCD00058000
- PDSP1_001085
- PDSP2_001069
- AKOS015914091
- C28-H40-N2-O5
- CAS_119442
- CCG-204863
- DB12923
- GSK 796406
- NSC_119442
- SDCCGSBI-0050756.P002
- IDI1_033853
- NCGC00015686-03
- NCGC00015686-04
- NCGC00015686-05
- NCGC00015686-06
- NCGC00015686-07
- NCGC00015686-09
- NCGC00015686-10
- NCGC00015686-13
- NCGC00089760-02
- NCGC00089760-03
- NCGC00089760-04
- NCGC00089760-05
- AT-44300
- DA-63679
- HY-14276
- J13.326D
- LS-29040
- AB0000178
- ST2405982
- TC-159801
- CS-0002968
- NS00007539
- 5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-yl-2-(3,4,5-trimethoxyphenyl)pentanenitrile
- C13764
- D08009
- W-3784
- Q412127
- A1200992
- BRD-A52922642-001-02-9
- BRD-A52922642-001-03-7
- BRD-A52922642-003-01-7
- I14-44940
- Benzeneacetonitrile, alpha-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4,5-trimethoxy-alpha-(1-methylethyl)-
- 5-((3,4-Dimethoxyphenethyl)methylamino)-2-isopropyl-2-(3,4,5-trimethoxyphenyl)valeronitrile
- 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-isopropyl-2-(3,4,5-trimethoxyphenyl)valeronitrile
- Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4,5-trimethoxy-alpha-(1-methylethyl)-
- 5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-2-(3,4,5-trimethoxyphenyl)pentanenitrile
- 5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)-2-(3,4,5-trimethoxyphenyl)pentanenitrile
- (+/-)-alpha-[3-[(2-(3,4-Dimethoxyphenyl)ethyl)methylamino]propyl]-3,4,5-trimethoxy-alpha-(1-methylethyl)benzeneacetonitrile hydrochloride
- (+/-)-Methoxyverapamil; Benzeneacetonitrile, a-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4,5-trimethoxy-a-(1-methylethyl)-; Valeronitrile, 5-[(3,4-dimethoxyphenethyl)methylamino]-2-isopropyl-2-(3,4,5-trimethoxyphenyl)- (8CI); a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]met
- .ALPHA.-(3-((2-(3,4-DIMETHOXYPHENYL)ETHYL)METHYLAMINO)PROPYL)-3,4,5-TRIMETHOXY-.ALPHA.-(1-METHYLETHYL)BENZENEACETONITRILE
- .ALPHA.-ISOPROPYL-.ALPHA.-((N-METHYL-N-HOMOVERATRYL)-.GAMMA.-AMINOPROPYL)-3,4,5-TRIMETHOXYPHENYLACETONITRILE
- 16662-46-7
- 1696-81-7
- 5-(2-(3,4-dimethoxyphenyl)ethyl-methyl-amino)-2-isopropyl-2-(3,4,5-trimethoxyphenyl)pentanenitrile
- 5-[[2-(3,4-Dimethoxyphenyl)ethyl](methyl)amino]-2-isopropyl-2-(3,4,5-trimethoxyphenyl)pentanenitrile #
- 56949-78-1
- alpha-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4,5-trimethoxy-alpha-isopropylbenzeneacetonitrile
- alpha-[3-[N-[2-(3,4-Dimethoxyphenyl)ethyl]-N-methylamino]propyl]-3,4,5-trimethoxy-alpha-isopropylbenzeneacetonitrile
- Benzeneacetonitrile, |A-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4,5-trimethoxy-|A-(1-methylethyl)-
- Benzeneacetonitrile, a-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4,5-trimethoxy-a-(1-methylethyl)-